Sarah L. Buchan

2.6k total citations
26 papers, 1.1k citations indexed

About

Sarah L. Buchan is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Sarah L. Buchan has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Sarah L. Buchan's work include Immune Cell Function and Interaction (14 papers), Immunotherapy and Immune Responses (14 papers) and T-cell and B-cell Immunology (12 papers). Sarah L. Buchan is often cited by papers focused on Immune Cell Function and Interaction (14 papers), Immunotherapy and Immune Responses (14 papers) and T-cell and B-cell Immunology (12 papers). Sarah L. Buchan collaborates with scholars based in United Kingdom, United States and France. Sarah L. Buchan's co-authors include Aymen Al‐Shamkhani, Anne Rogel, Freda K. Stevenson, Jason Rice, Vadim Y. Taraban, Jane E. Willoughby, Tim Elliott, Peter Johnson, Stephen M. Thirdborough and Tomasz Ślebioda and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Sarah L. Buchan

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah L. Buchan United Kingdom 18 829 434 392 102 81 26 1.1k
Wouter Scheper Netherlands 11 924 1.1× 773 1.8× 310 0.8× 69 0.7× 95 1.2× 15 1.3k
Michelle Kinder United States 13 1.0k 1.2× 600 1.4× 429 1.1× 101 1.0× 141 1.7× 21 1.5k
Remko Schotte Netherlands 14 1.4k 1.7× 923 2.1× 468 1.2× 133 1.3× 99 1.2× 23 1.8k
Juan J. Pérez‐Villar Spain 18 1.7k 2.1× 592 1.4× 315 0.8× 73 0.7× 74 0.9× 24 2.0k
Victor Levitsky Sweden 17 1.1k 1.3× 627 1.4× 313 0.8× 47 0.5× 46 0.6× 37 1.5k
Drew C. Deniger United States 14 737 0.9× 874 2.0× 302 0.8× 166 1.6× 98 1.2× 18 1.2k
Susanne H.C. Baumeister United States 10 598 0.7× 637 1.5× 175 0.4× 68 0.7× 38 0.5× 19 1.0k
Annette Arnold Germany 12 827 1.0× 522 1.2× 262 0.7× 198 1.9× 45 0.6× 17 1.2k
Arabella Mazzocchi Italy 18 1.1k 1.3× 498 1.1× 489 1.2× 82 0.8× 128 1.6× 44 1.3k
Franco Marincola United States 14 1.1k 1.3× 627 1.4× 385 1.0× 96 0.9× 54 0.7× 20 1.3k

Countries citing papers authored by Sarah L. Buchan

Since Specialization
Citations

This map shows the geographic impact of Sarah L. Buchan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah L. Buchan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah L. Buchan more than expected).

Fields of papers citing papers by Sarah L. Buchan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah L. Buchan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah L. Buchan. The network helps show where Sarah L. Buchan may publish in the future.

Co-authorship network of co-authors of Sarah L. Buchan

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah L. Buchan. A scholar is included among the top collaborators of Sarah L. Buchan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah L. Buchan. Sarah L. Buchan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buchan, Sarah L.. (2024). CTLA-4: Checkpoints beyond the membrane. Molecular Therapy. 32(2). 279–281. 4 indexed citations
2.
Allen, Joel D., Sarah L. Buchan, Jinny Kim, et al.. (2023). Fcγ receptor binding is required for maximal immunostimulation by CD70-Fc. Frontiers in Immunology. 14. 1252274–1252274. 1 indexed citations
3.
Smith, Emily & Sarah L. Buchan. (2023). Skewed perception of personal behaviour as a contributor to antibiotic resistance and underestimation of the risks. PLoS ONE. 18(11). e0293186–e0293186. 3 indexed citations
4.
Rogel, Anne, Stephen M. Thirdborough, Florence Depontieu, et al.. (2022). Fcγ receptor–mediated cross-linking codefines the immunostimulatory activity of anti-human CD96 antibodies. JCI Insight. 7(19). 8 indexed citations
5.
Buchan, Sarah L., Stephen M. Thirdborough, Vadim Y. Taraban, et al.. (2018). PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell–Driven Antitumor Immunity. Clinical Cancer Research. 24(10). 2383–2394. 82 indexed citations
6.
Rogel, Anne, et al.. (2017). Akt signaling is critical for memory CD8 + T-cell development and tumor immune surveillance. Proceedings of the National Academy of Sciences. 114(7). E1178–E1187. 42 indexed citations
7.
Buchan, Sarah L., Anne Rogel, & Aymen Al‐Shamkhani. (2017). The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy. Blood. 131(1). 39–48. 179 indexed citations
8.
Willoughby, Jane E., Jonathan P. Kerr, Anne Rogel, et al.. (2014). Differential Impact of CD27 and 4-1BB Costimulation on Effector and Memory CD8 T Cell Generation following Peptide Immunization. The Journal of Immunology. 193(1). 244–251. 43 indexed citations
9.
Buchan, Sarah L., Teresa Manzo, Barry Flutter, et al.. (2014). OX40- and CD27-Mediated Costimulation Synergizes with Anti–PD-L1 Blockade by Forcing Exhausted CD8+ T Cells To Exit Quiescence. The Journal of Immunology. 194(1). 125–133. 65 indexed citations
10.
Buchan, Sarah L. & Aymen Al‐Shamkhani. (2012). Distinct Motifs in the Intracellular Domain of Human CD30 Differentially Activate Canonical and Alternative Transcription Factor NF-κB Signaling. PLoS ONE. 7(9). e45244–e45244. 23 indexed citations
11.
Ślebioda, Tomasz, Tania F. Rowley, John R. Ferdinand, et al.. (2011). Triggering of TNFRSF25 promotes CD8+ T‐cell responses and anti‐tumor immunity. European Journal of Immunology. 41(9). 2606–2611. 52 indexed citations
12.
Taraban, Vadim Y., Tomasz Ślebioda, Jane E. Willoughby, et al.. (2010). Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia. Mucosal Immunology. 4(2). 186–196. 75 indexed citations
13.
Rice, Jason, Michelle L. Dossett, Claes Öhlén, et al.. (2008). DNA fusion gene vaccination mobilizes effective anti‐leukemic cytotoxic T lymphocytes from a tolerized repertoire. European Journal of Immunology. 38(8). 2118–2130. 15 indexed citations
14.
Rice, Jason, Sarah L. Buchan, Hamlata Dewchand, Elizabeth Simpson, & Freda K. Stevenson. (2004). DNA Fusion Vaccines Induce Targeted Epitope-Specific CTLs against Minor Histocompatibility Antigens from a Normal or Tolerized Repertoire. The Journal of Immunology. 173(7). 4492–4499. 23 indexed citations
15.
Stevenson, Freda K., Christian H. Ottensmeier, Peter Johnson, et al.. (2004). DNA vaccines to attack cancer. Proceedings of the National Academy of Sciences. 101(suppl_2). 14646–14652. 89 indexed citations
16.
Mockridge, C. Ian, Anisur Rahman, Sarah L. Buchan, et al.. (2003). Common Patterns of B Cell Perturbation and Expanded V4-34 Immunoglobulin Gene Usage in Autoimmunity and Infection. Autoimmunity. 37(1). 9–15. 30 indexed citations
17.
Rice, Jason, Sarah L. Buchan, & Freda K. Stevenson. (2002). Critical Components of a DNA Fusion Vaccine Able to Induce Protective Cytotoxic T Cells Against a Single Epitope of a Tumor Antigen. The Journal of Immunology. 169(7). 3908–3913. 57 indexed citations
18.
Potter, Kathleen N., C. Ian Mockridge, Anisur Rahman, et al.. (2002). Disturbances in peripheral blood B cell subpopulations in autoimmune patients. Lupus. 11(12). 872–877. 33 indexed citations
19.
Rice, Jason, Tim Elliott, Sarah L. Buchan, & Freda K. Stevenson. (2001). DNA Fusion Vaccine Designed to Induce Cytotoxic T Cell Responses Against Defined Peptide Motifs: Implications for Cancer Vaccines. The Journal of Immunology. 167(3). 1558–1565. 81 indexed citations
20.
Wilkins, Bridget S., Sarah L. Buchan, Joshua D. Webster, & David Jones. (2001). Tryptase‐positive mast cells accompany lymphocytic as well as lymphoplasmacytic lymphoma infiltrates in bone marrow trephine biopsies. Histopathology. 39(2). 150–155. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wouter Scheper Breakdown of academic impact, for papers by Michelle Kinder Breakdown of academic impact, for papers by Remko Schotte Breakdown of academic impact, for papers by Juan J. Pérez‐Villar Breakdown of academic impact, for papers by Victor Levitsky Breakdown of academic impact, for papers by Drew C. Deniger Breakdown of academic impact, for papers by Susanne H.C. Baumeister Breakdown of academic impact, for papers by Annette Arnold Breakdown of academic impact, for papers by Arabella Mazzocchi Breakdown of academic impact, for papers by Franco Marincola
Rankless by CCL
2026